Filing Flows › 8-K events › Pmgc Holdings
Pmgc Holdings: entry into a material definitive agreement
Form 8-K filed Nov 2, 2026 · items 1.01
What the filing says
Subscription Agreement for Secured Debentures of Nuclea Energy Canada Inc. On October 30, 2026, PMGC Holdings Inc. (the “Company”) entered into a Subscription Agreement (the “Subscription Agreement”) with Nuclea Energy Canada Inc., a corporation existing under the Business Corporations Act (British Columbia) (“Nuclea C
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Pmgc Holdings at a glance
Pmgc Holdings, Q2 2026: revenue $1.3M, operating margin -225.1%. The chart follows the revenue to costs, profit and cash.
Pmgc Holdings: every quarter, Q/Q and Y/Y, holders and guidance →
Pmgc Holdings’s other material 8-Ks
- Nov 5, 2026 — Entry into a material definitive agreement NorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide
Other recent mergers and acquisitions
- Starry Sea Acquisition Nov 6, 2026
- Kontoor Brands Nov 6, 2026
- Terawulf Nov 6, 2026
- Plains GP Holdings LP Nov 6, 2026
- Pono Capital Four Nov 6, 2026
- HeartSciences Nov 6, 2026
- Agility Robotics Nov 6, 2026
- Crown PropTech Acquisitions Nov 6, 2026
- Rallybio Nov 6, 2026
- Fox Nov 6, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.